Korn, S., Schmidt, O., Timmermann, H., Watz, H., Gappa, M., Radwan, A., . . . Lommatzsch, M. (2024). Real-world characteristics of patients with severe asthma prior to starting dupilumab: The ProVENT study. Respiration, 103(1), . https://doi.org/10.1159/000535390
Chicago-Zitierstil (17. Ausg.)Korn, Stephanie, et al. "Real-world Characteristics of Patients with Severe Asthma Prior to Starting Dupilumab: The ProVENT Study." Respiration 103, no. 1 (2024). https://doi.org/10.1159/000535390.
MLA-Zitierstil (9. Ausg.)Korn, Stephanie, et al. "Real-world Characteristics of Patients with Severe Asthma Prior to Starting Dupilumab: The ProVENT Study." Respiration, vol. 103, no. 1, 2024, https://doi.org/10.1159/000535390.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.